NEW YORK (GenomeWeb) – GATC Biotech today announced it has signed a worldwide commercial agreement with Molecular Health.

Under the terms of the agreement, GATC Biotech will market and support Molecular Health's TreatmentMap tumor profiling system, which includes a next-generation sequencing-based test which looks at 500 cancer-linked genes to guide treatment strategies. Molecular Health has launched TreatmentMap in the US and in Germany and GATC Biotech will work with the company to increase adoption of the technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.